The ASX’s long weekend gave banking bosses the chance to reflect on the first half of the 2022 investment banking year, and get ready for the opening round of bonus talks with headquarters offshore.
The key takeaway is that last year’s run of dream deals – and dream dealmaking conditions – is over. M&A volumes have held up thanks to KKR’s (not yet signed) deal to acquire Ramsay Health Care, while ECM activity has tanked.
We look at who’s who on the league tables to date and, as is often the case approaching the halfway mark, the winners were dictated by who landed one or two big mandates.
With just two weeks to go to the end of June, investment bankers everywhere would be tallying up their fees and thinking how they look for bonus talks before Christmas.
